Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PENS vs TENS for Hand Function in Multiple Sclerosis

NCT: NCT07546318 · COMPLETED

NCT IDNCT07546318
StatusCOMPLETED
Start Date2026-01-01
Completion2026-04-14

Brief Summary

This randomized, parallel, single-blind clinical trial aims to compare the immediate and short-term effects of percutaneous electrical nerve stimulation (PENS) versus transcutaneous electrical nerve stimulation (TENS), applied simultaneously to the median, radial, and ulnar nerves, on hand function in people with multiple sclerosis. Participants will be assessed at baseline, immediately after the intervention, and 72 hours later. Outcomes include fine manual dexterity, gross manual dexterity, pinch strength, and tactile sensitivity.

Frequently Asked Questions

What is PENS vs TENS for Hand Function in Multiple Sclerosis?

PENS vs TENS for Hand Function in Multiple Sclerosis is a clinical trial registered under NCT07546318. Current status: COMPLETED.

What is the status of NCT07546318?

The current status of NCT07546318 (PENS vs TENS for Hand Function in Multiple Sclerosis) is: COMPLETED.

When did PENS vs TENS for Hand Function in Multiple Sclerosis start?

PENS vs TENS for Hand Function in Multiple Sclerosis started on 2026-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.